Mahmut Gozelle

Design, Synthesis, and Cholinesterase Inhibitory Evaluation of Novel 5-(Benzylthio)-1,3,4-thiadiazole Derivatives

Alzheimer's disease remains one of the leading causes of dementia, and the development of novel cholinesterase inhibitors continues to attract considerable interest for symptomatic treatment. In this study, a series of five novel 5-(benzylthio)-1,3,4-thiadiazole derivatives beari...